Arbutus Biopharma (ABUS) EBT Margin Growth (3y) (2016 - 2026)
Arbutus Biopharma (ABUS) EBT Margin Growth (3y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
49,756.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
441.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Arbutus Biopharma |
882.62 Mn |
882.62 Mn |
- |
33,908.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
33,908.00 |
| Dec 31, 2025 |
-7,041.00 |
| Sep 30, 2025 |
-116,610.00 |
| Jun 30, 2025 |
12,295.00 |
| Mar 31, 2025 |
-130,060.00 |
| Dec 31, 2024 |
-12,906.00 |
| Sep 30, 2024 |
-89,930.00 |
| Jun 30, 2024 |
-31,405.00 |
| Mar 31, 2024 |
-39,068.00 |
| Dec 31, 2023 |
-18,608.00 |
| Sep 30, 2023 |
79,985.00 |
| Jun 30, 2023 |
56,292.00 |
| Mar 31, 2023 |
68,530.00 |
| Dec 31, 2022 |
117,254.00 |
| Sep 30, 2022 |
281,361.00 |
| Jun 30, 2022 |
347,079.00 |
| Mar 31, 2022 |
333,432.00 |
| Dec 31, 2021 |
42,251.00 |
| Sep 30, 2021 |
123,832.00 |
| Jun 30, 2021 |
-108,089.00 |
